Evidence map›Paper›PMID 30038060›Full record

ArticleBioscience reports2019

The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.

Xu Li, Junjie Xing, Hantao Wang, Enda Yu

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. The MYC/TXNIP axis mediates NCL-Suppressed CD8Molecular medicine (Cambridge, Mass.) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Characterization ofBiomolecules · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xu LiDepartment of Colorectal Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China.
Junjie XingDepartment of Colorectal Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China.
Hantao WangDepartment of Colorectal Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China.
Enda YuDepartment of Colorectal Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China yuenda@163.com.
Second Military Medical University · CNChanghai Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence has uncovered that

Indexed as

Cell ProliferationDrug Resistance, NeoplasmSignal TransductionAnimalsBasic Helix-Loop-Helix ProteinsColorectal NeoplasmsEndothelial PAS Domain-Containing Protein 1Enhancer of Zeste Homolog 2 ProteinFemaleGene Expression Regulation, NeoplasticHT29 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitMiceMice, Inbred BALB CMice, NudeBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitNeoplasm ProteinsReactive Oxygen SpeciesSLC34A2 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIbchemo-resistancecolorectal cancerEZH2HIF-1αROSSLC34A2

Identifiers

PMID30038060
PMCPMC6527931
OpenAlexW2884698122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.